6-(4-Azido-2-nitrophenylamino)hexanoic Acid N-Hydroxysuccinimide Ester - CAS 64309-05-3
Catalog: |
BB032432 |
Product Name: |
6-(4-Azido-2-nitrophenylamino)hexanoic Acid N-Hydroxysuccinimide Ester |
CAS: |
64309-05-3 |
Synonyms: |
6-(4-azido-2-nitroanilino)hexanoic acid (2,5-dioxo-1-pyrrolidinyl) ester; (2,5-dioxopyrrolidin-1-yl) 6-(4-azido-2-nitroanilino)hexanoate |
IUPAC Name: | (2,5-dioxopyrrolidin-1-yl) 6-(4-azido-2-nitroanilino)hexanoate |
Description: | 6-(4-Azido-2-nitrophenylamino)hexanoic Acid N-Hydroxysuccinimide Ester (CAS# 64309-05-3 ) is a useful research chemical. |
Molecular Weight: | 390.35 |
Molecular Formula: | C16H18N6O6 |
Canonical SMILES: | C1CC(=O)N(C1=O)OC(=O)CCCCCNC2=C(C=C(C=C2)N=[N+]=[N-])[N+](=O)[O-] |
InChI: | InChI=1S/C16H18N6O6/c17-20-19-11-5-6-12(13(10-11)22(26)27)18-9-3-1-2-4-16(25)28-21-14(23)7-8-15(21)24/h5-6,10,18H,1-4,7-9H2 |
InChI Key: | NGXDNMNOQDVTRL-UHFFFAOYSA-N |
Appearance: | Red-brown or light orange powder |
MDL: | MFCD00049058 |
LogP: | 3.10296 |
Publication Number | Title | Priority Date |
AU-2021105450-A4 | Administration Carrier Containing TGFα-Saporin and Preparation Method of Administration Carrier | 20210813 |
WO-2021207636-A2 | Compositions and methods for the treatment of protein aggregation disorders | 20200410 |
US-2021299266-A1 | Compositions and methods of treating muscle dystrophy | 20200327 |
WO-2021195469-A1 | Compositions and methods of treating muscle dystrophy | 20200327 |
US-2021301290-A1 | Compositions and methods of treating facioscapulohumeral muscular dystrophy | 20200319 |
PMID | Publication Date | Title | Journal |
14712498 | 20040301 | Effect of vitamin D analog (1alpha hydroxy D5) immunoconjugated to Her-2 antibody on breast cancer | International journal of cancer |
12684659 | 20030501 | Targeting colon cancer cells with genistein-17.1A immunoconjugate | International journal of oncology |
12580772 | 20030201 | Growth of human endothelial cells on different concentrations of Gly-Arg-Gly-Asp grafted chitosan surface | Artificial organs |
12361619 | 20021201 | Growth of human endothelial cells on photochemically grafted Gly-Arg-Gly-Asp (GRGD) chitosans | Biomaterials |
11531712 | 20010801 | Growth of endothelial cells on different concentrations of Gly-Arg-Gly-Asp photochemically grafted in polyethylene glycol modified polyurethane | Artificial organs |
Complexity: | 643 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 390.12878232 |
Formal Charge: | 0 |
Heavy Atom Count: | 28 |
Hydrogen Bond Acceptor Count: | 9 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 390.12878232 |
Rotatable Bond Count: | 10 |
Topological Polar Surface Area: | 136 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 3.2 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
-
[3735-92-0]
Methyl dimethyldithiocarbamate
-
[597-35-3]
ethylsulfone
-
[16208-48-3]
Ethanesulfonic acid, 2,2'-trithiodi-, disodium salt
-
[30360-19-1]
N,N'-Diethyl-N''-isopropyl-1,3,5-triazine-2,4,6-triamine
-
[144222-34-4]
(1R,2R)-(-)-N-p-Tosyl-1,2-diphenylethylenediamine
-
[852913-16-7]
N-[3,5-Bis(trifluoromethyl)phenyl]-N-[(8a,9S)-6-methoxy-9-cinchonanyl]thiourea
INDUSTRY LEADERS TRUST OUR PRODUCTS